Table 2 Characteristics of included studies which the durations of follow-up were greater than 15 days but less than or equal to 45 days.
Author, year | Pts(n) | research region | Gender (male, n) | Age(years) | Stone location | Stone size, mm | SWL sessions | Treatment | SFRs, % | Follow-up |
|---|---|---|---|---|---|---|---|---|---|---|
Mohamed, 2013 | 65/65 | Egypt | 41/39 | 40.1/43.8 | Ureteral | 5–15 | 1–3 | Tamsulosin 0.4 mg/non-Placebo | 85/89 | 30 days |
Park, 2013 | 44/44 | Korea | 29/28 | 46.2/47.6 | Proximal ureteral | 9.2/9.6 | 1/1 | Tamsulosin 0.2 mg/non-Placebo | 84/66 | 3 weeks |
Elkoushy, 2012 | 63/63 | Egypt | 44/39 | 52.8/49.4 | Renal and upper ureteral | 11.1/10.5 | 1.5/1.9 | Tamsulosin 0.4 mg/non-Placebo | 55/46 | 3 weeks |
Georgiev, 2011 | 99/87 | Bulgaria | 67/54 | 54/51 | Renal and ureteral | 5–20 | 1–2 | Tamsulosin 0.4 mg/non-Placebo | 74/56 | 4 weeks |
Romics, 2011 | 106/98 | Germany | 62/53 | 51/48 | Renal | 3–20 | 1/1 | Rowatinex 300 mg/Placebo | 44/30 | 4 weeks |
Singh, 2011 | 59/58 | India | 44/41 | 32.2/36.0 | Upper ureteral | 6–15 | 1/2 | Tamsulosin 0.4 mg/non-Placebo | 85/71 | 1 months |
Vicentini, 2011 | 38/35/38 | Brazil | 16/18/24 | 47.3/48.6/45.7 | Renal | 10/10/12 | 1/1/1 | Tamsulosin 0.4 mg/ Nifedipine 20 mg/Placebo | 61/49/37 | 30 days |
Hussein, 2010 | 67/69 | Egypt | 40/45 | 44/40 | Renal | 4–24 | 1–2 | Tamsulosin 0.4 mg/non-Placebo | 46/32 | 1 months |
Djaladat, 2009 | 50/50 | Iran | 30/29 | 38.3/40.9 | Renal | 10–20 | 1/1 | Rowatinex 300 mg/Placebo | 24/18 | 4 weeks |
Kobayashi, 2008 | 38/34 | Japan | NA | 56.8/52.3 | Ureteral | 10.61/9.85 | 1/1 | Tamsulosin 0.2 mg/non-Placebo | 84/88 | 28 days |
Naja, 2008 | 51/65 | India | 36/43 | 37.1/39.4 | Renal | 12.1/13.1 | 1.66/2.16 | Tamsulosin 0.4 mg/non-Placebo | 53/31 | 3 weeks |
Bhagat, 2007 | 29/29 | America | 22/24 | 35.9/42.3 | Renal and ureteral | 6–24 | 1/1 | Tamsulosin 0.4 mg/Placebo | 97/79 | 30 days |
Gravas, 2007 | 30/31 | Greece | 18/20 | 48.8/49.2 | Distal ureteral | 8.3/8.5 | 1/1 | Tamsulosin 0.4 mg/non-Placebo | 63/52 | 4 weeks |
Resim, 2005 | 32/35 | Turkey | 21/22 | 39/37 | Lower ureteral | 21/20 | N/A | Tamsulosin 0.4 mg/non-Placebo | 75/66 | 6 weeks |
Gravina, 2005 | 65/65 | Italy | 28/29 | 48.4/47.9 | Renal | 14.2/14.6 | 1/1 | Tamsulosin 0.4 mg/non-Placebo | 55/46 | 4 weeks |
Porpiglia, 2002 | 40/40 | Italy | 27/25 | 50/46 | Ureteral | 11.6/10.1 | 1/1 | Nifedipine 30 mg/non-Placebo | 75/50 | 45 days |
